Hester Biosciences P/B Ratio
Hester Biosciences P/B ratio. Hester Biosciences (HESTERBIO) P/B ratio is 4.24 (High), book value per share ₹408.89 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse HESTERBIO balance sheet details for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
HESTERBIO P/B Ratio — Valuation Insights & Book Value Analysis
Hester Biosciences price-to-book ratio interpretation, valuation status and historical context — current P/B 4.24 (High). For live price, earnings yield and the full fundamental profile, see HESTERBIO share price.
- Stock appears overvalued with PB of 4.24, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 23.9% below historical average
- Trading at premium to sector average PB of -0.3
Hester Biosciences P/B Ratio Historical Trend
HESTERBIO annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read HESTERBIO dividend yield for the complete payout history and dividend yield track record.
HESTERBIO Historical P/B Ratio — Book Value Per Share & Year-End Price
Hester Biosciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 5.75 | ₹408.89 | ₹2352.10 | ₹368 | High |
| 2025 | 4.4 | ₹363.33 | ₹1599.70 | ₹327 | High |
| 2024 | 7.13 | ₹336.67 | ₹2399.40 | ₹303 | High |
| 2023 | 4.54 | ₹321.11 | ₹1457.90 | ₹289 | High |
| 2022 | 6.04 | ₹296.67 | ₹1791.65 | ₹267 | High |
HESTERBIO vs Healthcare Peers — P/B Ratio Comparison
Hester Biosciences P/B 4.24 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |